Blue Owl's Co-CEOs, Doug Ostrover and Marc Lipschultz, are confident in the company's business model and growth potential. They emphasized the firm's strong expansion across all sectors and the creation of new capital solutions for emerging markets.
The economic outcome might determine private debt success. If a soft landing isn't achieved, companies could sustain unviable businesses, resembling Ponzi schemes. Only 46% of such could remain cash flow positive under mild stress, says S&P Global Ratings.
Blue Owl Capital's high price-to-sales ratio may be warranted given its robust revenue growth and bright outlook. If revenue growth continues to surpass industry average, investors may find comfort in the high P/S ratio, anticipating steady near-term share prices.
Blue Owl's Co-CEOs express confidence in their resilient business model, poised to benefit from investors' demand for differentiated products, predictable income, and downside protection. They highlight the company's remarkable growth and global potential.
Gainers: •$リペア・セラピューティクス(RPTX.US)$+26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib) •$チューイ A(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered) •$ユーアイパス(PATH.US)$+11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million) •$ピュア ストレージ A(PSTG.US)$+10.6% (In reaction to earnings) •$クレド テクノロジー グループ(CRDO.US)$+10.2% (In reaction ...
ブルー アウル キャピタル Aに関するコメント
• $Revlon(REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $ユナイテッド ステーツ スチール(X.US)$ +6.4% (issues upside EPS guidance),
• $エリントン・ファイナンシャル(EFC.US)$ +5% (reports book value per share)
• $オーロラ・モバイル(JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $シティ トレンズ(CTRN.US)$ +4.4% (names new CFO)
• $ロク(ROKU.US)$ +4.2% (ROKU an...
• $セレス セラピューティクス(MCRB.US)$ : Jefferies Upgrades to Buy from Hold
• $フェラーリ(RACE.US)$ : Kepler Upgrades to Hold from Reduce
Downgrades
• $ダッチ ブロス A(BROS.US)$ : JPMorgan Downgrades to Neutral from Overweight - PT $40
• $キャノピー グロース(CGC.US)$ : BMO Capital Downgrades to Underperform from Market Perform - PT Cdn$2.50 (from Cdn$6)
• $カズー グループ(CZOO.US)$ : Citigroup Downgrades to Neutral from Buy - PT $1.50 (from $9)
• $チャート インダストリーズ(GTLS.US)$ : Barcla...
• $リペア・セラピューティクス(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $チューイ A(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $ユーアイパス(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $ピュア ストレージ A(PSTG.US)$ +10.6% (In reaction to earnings)
• $クレド テクノロジー グループ(CRDO.US)$ +10.2% (In reaction ...
まだコメントはありません